115 related articles for article (PubMed ID: 11097203)
1. Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression.
Vacca A; Ribatti D; Ria R; Pellegrino A; Bruno M; Merchionne F; Dammacco F
Dev Immunol; 2000; 7(2-4):77-88. PubMed ID: 11097203
[TBL] [Abstract][Full Text] [Related]
2. Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9.
Vacca A; Moretti S; Ribatti D; Pellegrino A; Pimpinelli N; Bianchi B; Bonifazi E; Ria R; Serio G; Dammacco F
Eur J Cancer; 1997 Sep; 33(10):1685-92. PubMed ID: 9389934
[TBL] [Abstract][Full Text] [Related]
3. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma.
Vacca A; Ribatti D; Presta M; Minischetti M; Iurlaro M; Ria R; Albini A; Bussolino F; Dammacco F
Blood; 1999 May; 93(9):3064-73. PubMed ID: 10216103
[TBL] [Abstract][Full Text] [Related]
5. Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin.
Yakubenko VP; Lobb RR; Plow EF; Ugarova TP
Exp Cell Res; 2000 Oct; 260(1):73-84. PubMed ID: 11010812
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.
Suzuki M; Iizasa T; Fujisawa T; Baba M; Yamaguchi Y; Kimura H; Suzuki H
Invasion Metastasis; 1998-1999; 18(3):134-41. PubMed ID: 10474026
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow angiogenesis and plasma cell angiogenic and invasive potential in patients with active multiple myeloma.
Vacca A; Ribatti D; Roccaro AM; Ria R; Palermo L; Dammacco F
Acta Haematol; 2001; 106(4):162-9. PubMed ID: 11815713
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of matrix metalloproteinase-9 in murine 5T33 multiple myeloma cells by interaction with bone marrow endothelial cells.
Van Valckenborgh E; Bakkus M; Munaut C; Noël A; St Pierre Y; Asosingh K; Van Riet I; Van Camp B; Vanderkerken K
Int J Cancer; 2002 Oct; 101(6):512-8. PubMed ID: 12237890
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between VEGF and MMP-2, MMP-9 in 82 patients with acute myeloid leukemia].
Yang L; Dong ZR; Wen SP; Pan L; Zhang XJ; Luo JM; Xu SR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):15-20. PubMed ID: 16584583
[TBL] [Abstract][Full Text] [Related]
10. Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture.
Park YH; Ryu HS; Choi DS; Chang KH; Park DW; Min CK
Int J Gynecol Cancer; 2003; 13(1):53-60. PubMed ID: 12631221
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases 2 and 9 in situ mRNA expression in colorectal tumors from Iraqi patients.
Ahmed MM; Mohammed SH
Indian J Pathol Microbiol; 2011; 54(1):7-14. PubMed ID: 21393869
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous and cytokine-evoked production of matrix metalloproteinases by bone marrow and peripheral blood pre-B cells in childhood acute lymphoblastic leukaemia.
Pegahi R; Poyer F; Legrand E; Cazin L; Vannier JP; Lamacz M
Eur Cytokine Netw; 2005 Sep; 16(3):223-32. PubMed ID: 16266864
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinase-2, -9, -14, and tissue inhibitors of metalloproteinase-1, -2, -3 in the endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy.
Wang H; Li Q; Shao L; Zhu C
Biol Reprod; 2001 Jul; 65(1):31-40. PubMed ID: 11420220
[TBL] [Abstract][Full Text] [Related]
14. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases by human plasma cells and B lymphocytes.
Di Girolamo N; Tedla N; Lloyd A; Wakefield D
Eur J Immunol; 1998 Jun; 28(6):1773-84. PubMed ID: 9645358
[TBL] [Abstract][Full Text] [Related]
16. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
[TBL] [Abstract][Full Text] [Related]
17. Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines.
Liu Z; Ivanoff A; Klominek J
Int J Cancer; 2001 Mar; 91(5):638-43. PubMed ID: 11267973
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization.
Ma DH; Chen JK; Kim WS; Hao YX; Wu HC; Tsai RJ; Hwang DG; Zhang F
Ophthalmic Res; 2001; 33(6):353-62. PubMed ID: 11721189
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
20. Posttranscriptional stimulation of endothelial cell matrix metalloproteinases 2 and 1 by endothelioma cells.
Taraboletti G; Sonzogni L; Vergani V; Hosseini G; Ceruti R; Ghilardi C; Bastone A; Toschi E; Borsotti P; Scanziani E; Giavazzi R; Pepper MS; Stetler-Stevenson WG; Bani MR
Exp Cell Res; 2000 Aug; 258(2):384-94. PubMed ID: 10896789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
